-
2
-
-
29244449354
-
Prostaglandins and cancer
-
Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006;55:115-122
-
(2006)
Gut
, vol.55
, pp. 115-122
-
-
Wang, D.1
Dubois, R.N.2
-
3
-
-
0346368096
-
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
-
Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003;4:431-436
-
(2003)
Cancer Cell
, vol.4
, pp. 431-436
-
-
Dannenberg, A.J.1
Subbaramaiah, K.2
-
4
-
-
13744254574
-
Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention
-
DOI 10.1200/JCO.2005.09.112
-
Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, Dubois RN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 2005;23:254-266 (Pubitemid 46206877)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.2
, pp. 254-266
-
-
Dannenberg, A.J.1
Lippman, S.M.2
Mann, J.R.3
Subbaramaiah, K.4
Dubois, R.N.5
-
5
-
-
0033105360
-
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
-
Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59:991-994
-
(1999)
Cancer Res
, vol.59
, pp. 991-994
-
-
Chan, G.1
Boyle, J.O.2
Yang, E.K.3
-
6
-
-
0042334817
-
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma
-
Cohen EG, Almahmeed T, Du B, et al. Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma. Clin Cancer Res 2003;9:3425-3430
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3425-3430
-
-
Cohen, E.G.1
Almahmeed, T.2
Du, B.3
-
7
-
-
0033791318
-
Cyclooxygenases: Structural, cellular and molecular biology
-
Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 2000;69:145-182
-
(2000)
Annu Rev Biochem
, vol.69
, pp. 145-182
-
-
Smith, W.L.1
DeWitt, D.L.2
Garavito, R.M.3
-
8
-
-
0029783253
-
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
-
Subbaramaiah K, Telang N, Ramonetti JT. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996;56:4424-4429
-
(1996)
Cancer Res
, vol.56
, pp. 4424-4429
-
-
Subbaramaiah, K.1
Telang, N.2
Ramonetti, J.T.3
-
9
-
-
0032864706
-
Cyclooxygenase-2 alters transforming growth factor-β 1 response during intestinal tumorigenesis
-
O'Mahony CA, Beauchamp RD, Albo D, et al. Cyclooxygenase-2 alters transforming growth factor-β 1 response during intestinal tumorigenesis. Surgery 1999;126:364-370
-
(1999)
Surgery
, vol.126
, pp. 364-370
-
-
O'Mahony, C.A.1
Beauchamp, R.D.2
Albo, D.3
-
10
-
-
0029839213
-
Elevated cyclooxygenase-2 levels in Min mouse adenomas
-
Williams CS, Luongo C, Radhika A, et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenerology 1996;111:1134-1140
-
(1996)
Gastroenerology
, vol.111
, pp. 1134-1140
-
-
Williams, C.S.1
Luongo, C.2
Radhika, A.3
-
11
-
-
0034099597
-
Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
-
Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res 2000;6:2424-2430
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2424-2430
-
-
Shirahama, T.1
-
12
-
-
0035468642
-
Cyclooxygenase 2: A pharmacological target for the prevention of cancer
-
Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclooxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2001;2:544-551
-
(2001)
Lancet Oncol
, vol.2
, pp. 544-551
-
-
Dannenberg, A.J.1
Altorki, N.K.2
Boyle, J.O.3
-
13
-
-
26444543238
-
Mechanisms for the prevention of gastrointestinal cancer: The role of prostaglandin E2
-
Backlund MG, Mann JR, Dubois RN. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology 2005;69 Suppl 1:28-32.
-
(2005)
Oncology
, vol.69
, Issue.SUPPL. 1
, pp. 28-32
-
-
Backlund, M.G.1
Mann, J.R.2
Dubois, R.N.3
-
14
-
-
0034326837
-
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models
-
Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res 2000;60:6045-6051
-
(2000)
Cancer Res
, vol.60
, pp. 6045-6051
-
-
Williams, C.S.1
Watson, A.J.2
Sheng, H.3
Helou, R.4
Shao, J.5
Dubois, R.N.6
-
15
-
-
17744418769
-
The effect of Celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
-
Staeinbach G, Lynch PM, Phillips RK. The effect of Celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-1952
-
(2000)
N Engl J Med
, vol.342
, pp. 1946-1952
-
-
Staeinbach, G.1
Lynch, P.M.2
Phillips, R.K.3
-
16
-
-
0031799475
-
Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
-
Sawaoka H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998;247:G1061-7.
-
(1998)
Am J Physiol
, vol.247
-
-
Sawaoka, H.1
Kawano, S.2
Tsuji, S.3
-
17
-
-
0032750920
-
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
-
Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-1423
-
(1999)
Nat Med
, vol.5
, pp. 1418-1423
-
-
Jones, M.K.1
Wang, H.2
Peskar, B.M.3
-
18
-
-
0034089566
-
Host cyclooxygenase-2 modulates carcinoma growth
-
Ams CS, Tsujii M, Reese J, Dey SK, Dubois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105:1589-1594
-
(2000)
J Clin Invest
, vol.105
, pp. 1589-1594
-
-
Ams, C.S.1
Tsujii, M.2
Reese, J.3
Dey, S.K.4
Dubois, R.N.5
-
19
-
-
0035476842
-
COX-2 expression in dysplasia of the head and neck: Correlation with eIF4E
-
Nathan CA, Leskov IL, Lin M, et al. COX-2 expression in dysplasia of the head and neck: correlation with eIF4E. Cancer 2001;92:1888-1895
-
(2001)
Cancer
, vol.92
, pp. 1888-1895
-
-
Nathan, C.A.1
Leskov, I.L.2
Lin, M.3
-
20
-
-
4444324184
-
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck
-
Chen ZG, Zhang X, Li M, et al. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:5930-5939
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5930-5939
-
-
Chen, Z.G.1
Zhang, X.2
Li, M.3
-
21
-
-
0030040796
-
Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition
-
Ondrey FG, Juhn SK, Adams GL. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition. Laryngoscope 1996; 106:129-134
-
(1996)
Laryngoscope
, vol.106
, pp. 129-134
-
-
Ondrey, F.G.1
Juhn, S.K.2
Adams, G.L.3
-
22
-
-
0031034747
-
Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs
-
Sciocia KA, Snyderman CH, Ruege R, et al. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs. Am J Otolaryngol 1997;18:1-8.
-
(1997)
Am J Otolaryngol
, vol.18
, pp. 1-8
-
-
Sciocia, K.A.1
Snyderman, C.H.2
Ruege, R.3
-
23
-
-
0019447068
-
Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor
-
Panje WR. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol 1981;107:658-663
-
(1981)
Arch Otolaryngol
, vol.107
, pp. 658-663
-
-
Panje, W.R.1
-
25
-
-
0037099555
-
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
-
Shin DM, Glisson BS, Khuri FR, et al. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 2003;95:322-330
-
(2003)
Cancer
, vol.95
, pp. 322-330
-
-
Shin, D.M.1
Glisson, B.S.2
Khuri, F.R.3
-
26
-
-
0036916717
-
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions
-
Papadimitrakopoulou VA, Liu DD, Mao L, et al. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. Cancer Epidemiol Biomarkers Prev 2002; 11:1605-1610
-
(2002)
Cancer Epidemiol Biomarkers Prev
, vol.11
, pp. 1605-1610
-
-
Papadimitrakopoulou, V.A.1
Liu, D.D.2
Mao, L.3
-
27
-
-
0032824170
-
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract
-
Papadimitrakopoulou VA, Clayman GL, Shin DM, et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol 1999;125:1083-1089
-
(1999)
Arch Otolaryngol
, vol.125
, pp. 1083-1089
-
-
Papadimitrakopoulou, V.A.1
Clayman, G.L.2
Shin, D.M.3
-
28
-
-
2042533909
-
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression
-
Shin DM, Mao L, Papadimitrakopoulou VM, et al. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J Natl Cancer Inst 2000;92:69-73.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 69-73
-
-
Shin, D.M.1
Mao, L.2
Papadimitrakopoulou, V.M.3
-
29
-
-
0033942360
-
Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis
-
Tae K, El-Naggar AK, Yoo E, et al. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 2000;6:2821-2828
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2821-2828
-
-
Tae, K.1
El-Naggar, A.K.2
Yoo, E.3
-
30
-
-
35548972994
-
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
-
Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357: 1705-1715
-
(2007)
N Engl J Med
, vol.357
, pp. 1705-1715
-
-
Posner, M.R.1
Hershock, D.M.2
Blajman, C.R.3
-
31
-
-
0034495173
-
Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
-
Sung JY, Leung WK, Go MY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000;157:729-735
-
(2000)
Am J Pathol
, vol.157
, pp. 729-735
-
-
Sung, J.Y.1
Leung, W.K.2
Go, M.Y.3
-
32
-
-
4744351642
-
Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: Implication of HBx in upregulation of COX-2
-
Cheng AL, Chan HL, Leung WK, et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. Mod Pathol 2004; 17:1169-1179
-
(2004)
Mod Pathol
, vol.17
, pp. 1169-1179
-
-
Cheng, A.L.1
Chan, H.L.2
Leung, W.K.3
-
33
-
-
23144465154
-
COX-2 expression during early lung squamous cell carcinoma oncogenesis
-
Mascaux C, Martin B, Verdebout JM, Ninane V, Sculier JP. COX-2 expression during early lung squamous cell carcinoma oncogenesis. Eur Respir J 2005;26:198-203.
-
(2005)
Eur Respir J
, vol.26
, pp. 198-203
-
-
Mascaux, C.1
Martin, B.2
Verdebout, J.M.3
Ninane, V.4
Sculier, J.P.5
-
34
-
-
0028292482
-
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
-
Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994;54: 3153-3159
-
(1994)
Cancer Res
, vol.54
, pp. 3153-3159
-
-
Shin, D.M.1
Ro, J.Y.2
Hong, W.K.3
Hittelman, W.N.4
-
35
-
-
0027269712
-
Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker
-
Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hiittelman WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 1993;85:971-978
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 971-978
-
-
Shin, D.M.1
Voravud, N.2
Ro, J.Y.3
Lee, J.S.4
Hong, W.K.5
Hiittelman, W.N.6
-
38
-
-
0037904842
-
Cyclooxygenase-2 (COX-2) expression in high risk premalignant oral lesions
-
Sudb J, Ari R, Sondresen JE, Kildal W, Boysen M, Koppang HS. Cyclooxygenase-2 (COX-2) expression in high risk premalignant oral lesions. Oral Oncol 2003;39:497-505.
-
(2003)
Oral Oncol
, vol.39
, pp. 497-505
-
-
Sudb, J.1
Ari, R.2
Sondresen, J.E.3
Kildal, W.4
Boysen, M.5
Koppang, H.S.6
-
40
-
-
14644417232
-
Cyclooxygenase-1 and 2 expression in human oral mucosa, dysplasia and squamous cell carcinomas and their pathological significance
-
Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K. Cyclooxygenase-1 and 2 expression in human oral mucosa, dysplasia and squamous cell carcinomas and their pathological significance. Oral Oncol 2005;41:304-312
-
(2005)
Oral Oncol
, vol.41
, pp. 304-312
-
-
Shibata, M.1
Kodani, I.2
Osaki, M.3
Araki, K.4
Adachi, H.5
Ryoke, K.6
-
41
-
-
77951119455
-
Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC)
-
Grau JJ, Carles J, Monzó M, et al. Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC). Proc J Clin Oncol 2004;22:#5521.
-
(2004)
Proc J Clin Oncol
, vol.22
, pp. 5521
-
-
Grau, J.J.1
Carles, J.2
Monzó, M.3
|